Global Medical Probiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Probiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Medical probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of dietary supplements and healthcare products.
Medical Probiotics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Probiotics market is projected to reach US$ 92 million in 2034, increasing from US$ 70 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Pharmaceuticals and Dietary Supplements are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Probiotics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Medical Probiotics key manufacturers include DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc. DowDuPont, Chr. Hansen, Lallemand are top 3 players and held % sales share in total in 2022.
Medical Probiotics can be divided into Bifidobacterium, Lactobacillus and Others,, etc. Bifidobacterium is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Probiotics is widely used in various fields, such as Pharmaceuticals, Dietary Supplements and Others,, etc. Pharmaceuticals provides greatest supports to the Medical Probiotics industry development. In 2022, global % sales of Medical Probiotics went into Pharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Probiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
DowDuPont
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Novozymes
DSM
Ganeden
Glory Biotech
Unique Biotech
Winclove Probiotics
UAS Laboratories
Synbiotech
Segment by Type
Bifidobacterium
Lactobacillus
Others
Pharmaceuticals
Dietary Supplements
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Probiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Probiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Probiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Probiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Probiotics introduction, etc. Medical Probiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Medical Probiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Medical Probiotics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Probiotics market is projected to reach US$ 92 million in 2034, increasing from US$ 70 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Pharmaceuticals and Dietary Supplements are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Medical Probiotics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Medical Probiotics key manufacturers include DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc. DowDuPont, Chr. Hansen, Lallemand are top 3 players and held % sales share in total in 2022.
Medical Probiotics can be divided into Bifidobacterium, Lactobacillus and Others,, etc. Bifidobacterium is the mainstream product in the market, accounting for % sales share globally in 2022.
Medical Probiotics is widely used in various fields, such as Pharmaceuticals, Dietary Supplements and Others,, etc. Pharmaceuticals provides greatest supports to the Medical Probiotics industry development. In 2022, global % sales of Medical Probiotics went into Pharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Probiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
DowDuPont
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Novozymes
DSM
Ganeden
Glory Biotech
Unique Biotech
Winclove Probiotics
UAS Laboratories
Synbiotech
Segment by Type
Bifidobacterium
Lactobacillus
Others
Segment by Application
Pharmaceuticals
Dietary Supplements
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Probiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Probiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Probiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Probiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Probiotics introduction, etc. Medical Probiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Medical Probiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)